Description

In these series, our speakers will share their experience in bringing science to society. On the academic side, Prof. Toretsky, MD wil present the story of the development of small molecule therapeutic, TK216, from conception to clinical trial for improving patient outcomes in Ewing Sarcoma. On the industrial side, Dr. Jensen will give us a glimpse into how Ginkgo bioworks programs cells to create more sustainable and ethical biological alternatives.

The virtual seminar will take place from 15:00-17:00 CET. The event is free and open to all. Participants should register here to receive the Zoom link, which will be sent out 24 hours before the seminar.

Programme

When: May 26, 2021

Dr. Jeffrey Toretsky:
From a Design on a Napkin to a Clinical Trial: a 20 year quest to improve survival for Ewing sarcoma patients

In 2009, Dr. Toretsky and his team revealed the molecule called YK-4-279 that targets Ewing sarcoma with an article in Nature Medicine. A deeper investigation into the mechanism of YK-4-279 has led Dr. Toretsky into the world of phase separation and soft matter. An analog of YK-4-279 called TK216 is in human clinical trials and seems to be helping some patients. This is the story that will be told.

Dr. Jaide Jensen:
What if we could grow everything?        

Biology is the best manufacturing technology on the planet. Designing with nature is full of endless possibilities and complexities and we see the potential for biology to transform industries. But engineering living cells is hard—evolution is four billion years ahead of us, after all. At Ginkgo we’ve built our foundries and codebase so that we can better learn from and design with biology and translate ideas into new products and solutions that address some of the world’s biggest problems.

The event is free and open to all. Find more info and register here to receive the Zoom link ahead of the seminars: https://www.tilmeld.dk/cph-bioscience-snapshot-may-26